scispace - formally typeset
F

Fan Li Lin

Researcher at Taipei Medical University

Publications -  11
Citations -  187

Fan Li Lin is an academic researcher from Taipei Medical University. The author has contributed to research in topics: Retinal & Tumor necrosis factor alpha. The author has an hindex of 6, co-authored 10 publications receiving 138 citations. Previous affiliations of Fan Li Lin include Menzies Research Institute.

Papers
More filters
Journal ArticleDOI

Editor's Highlight: Periodic Exposure to Smartphone-Mimic Low-Luminance Blue Light Induces Retina Damage Through Bcl-2/BAX-Dependent Apoptosis.

TL;DR: The effects of periodic exposure to blue light‐emitting diode in a cell model and a rat retinal damage model caused fundus damage, decreased total retinal thickness, caused atrophy of photoreceptors, and injured neuron transduction in the retina.
Journal ArticleDOI

The natural retinoprotectant chrysophanol attenuated photoreceptor cell apoptosis in an N-methyl-N-nitrosourea-induced mouse model of retinal degenaration.

TL;DR: Investigating the retina-protective effect of chrysophanol, an active component of Cassia seed, in an N-methyl-N-nitrosourea (MNU)-induced mouse model of RP demonstrates that chrysophile provided neuroprotective effects and inhibited glial activation, suggesting that ch Chrysophanol might have therapeutic value for the treatment of human RP and other retinopathies.
Journal ArticleDOI

Theissenolactone C Exhibited Ocular Protection of Endotoxin-Induced Uveitis by Attenuating Ocular Inflammatory Responses and Glial Activation.

TL;DR: The findings indicated that LC53 exerted the ocular-protective effect through its inhibition on neuroinflammation, glial activation, and apoptosis in EIU, suggesting a therapeutic potential with down-regulation of the NF-κB signaling for uveitis and retinal inflammatory diseases.
Journal ArticleDOI

The fungus-derived retinoprotectant theissenolactone C improves glaucoma-like injury mediated by MMP-9 inhibition.

TL;DR: LC53 exerted a retinal protective effect through NF-κB inhibition and was highly potent against MMP-9 activities after high IOP-induced I/R injury, suggesting that LC53 would be a promising drug lead for glaucoma or related medical conditions attributed to retinal ischemia.